Thyroid disease

Dr. Rashmi Roy, Thyroid Surgeon at the Hospital for Endocrine Surgery, Wins Tampa Bay Business Woman of the Year Award in Health Category

Retrieved on: 
Thursday, April 27, 2023
Male, Thyroid, Internet, Seminole Hard Rock Hotel & Casino Hollywood, Workplace, Health, Cancer, Woman, Adrenal tumor, Patient, Thyroid disease, Hospital, Thyroid cancer, Hard Rock Cafe, Geography

TAMPA, Fla., April 27, 2023 /PRNewswire/ -- Tampa Bay Business & Wealth (TBBW) Magazine has named Dr. Rashmi Roy, Senior Thyroid Surgeon at the Hospital for Endocrine Surgery, the 2023 Tampa Bay Business Woman of the Year in the Health and Wellness Category.

Key Points: 
  • TAMPA, Fla., April 27, 2023 /PRNewswire/ -- Tampa Bay Business & Wealth (TBBW) Magazine has named Dr. Rashmi Roy, Senior Thyroid Surgeon at the Hospital for Endocrine Surgery, the 2023 Tampa Bay Business Woman of the Year in the Health and Wellness Category.
  • The Tampa Bay Business Women Awards recognize distinguished women leaders whose dedication to their industries and communities deserves particular recognition.
  • It specializes in all types of thyroid surgery, including scarless robotic thyroid surgery.
  • The Hospital for Endocrine Surgery is a first-of-its-kind facility, solely dedicated to the surgical treatment of thyroid, parathyroid and adrenal tumors and cancers.

ecoSPEARS Wins Edison Award for Breakthrough Solution to Eliminating ‘Forever Chemicals’

Retrieved on: 
Tuesday, April 25, 2023
Technology, Manufacturing, Other Energy, Utilities, Other Technology, Other Manufacturing, Green Technology, Environment, Energy, Sustainability, Chemicals, Plastics, Edison Awards, Food, United Nations, International Pollutants Elimination Network, Drinking water, Life, PFAS, IPEN, Cancer, Edison Award, Multimedia, Burn, Harvard University, Thomas Edison, Food packaging, Public health, Dioxin, Soil, NASA, Risk, UNEP, River, Water, National Green Corps, PCB, Polychlorinated biphenyl, Thyroid disease, Health, TH, Environmental remediation, Film industry, Cosmetics, Hazardous waste

ecoSPEARS, a Florida-based company with a breakthrough remediation solution, developed by NASA scientists, for eliminating PCBs and PFAS chemicals (known as ‘forever chemicals’), has been announced as the Bronze Edison Award winner for the category of Sustainability – Green Remediation.

Key Points: 
  • ecoSPEARS, a Florida-based company with a breakthrough remediation solution, developed by NASA scientists, for eliminating PCBs and PFAS chemicals (known as ‘forever chemicals’), has been announced as the Bronze Edison Award winner for the category of Sustainability – Green Remediation.
  • View the full release here: https://www.businesswire.com/news/home/20230424005972/en/
    The Edison Award recognizes ecoSPEARS as a new, clean technology for eliminating toxic environmental contaminants.
  • The ecoSPEARS approach to cleansing water and soil represents a paradigm shift in the ability to remediate toxic sites.
  • For the third year, the Edison Awards Judges recognize the ecoSPEARS technology as a game-changing innovation.

Environmental Protection Agency to Set New Standard on “Forever Chemicals”

Retrieved on: 
Monday, April 24, 2023
Well, Taste, Hardness, Liver, Maintenance, PFBS, Obesity, PFNA, Nitrate, Culligan, Drinking water, PFAS, NSF, Safe, Organic compound, PFOA, Cancer, Lead, Volatile organic compound, Cosmetics, Guam Environmental Protection Agency, RO, EPA, Food packaging, United States Environmental Protection Agency, Blood, Water, Fertility, GenX, Arsenic, Kidney, Perfluorohexanesulfonic acid, Thyroid disease, Filtration, Ministry of Defence, Environment, Safety, PFOS, Bottled water

For PFNA, PFHxS, PFBS, and GenX chemicals, the EPA proposes not one standard for each but a limit for a mix of them.

Key Points: 
  • For PFNA, PFHxS, PFBS, and GenX chemicals, the EPA proposes not one standard for each but a limit for a mix of them.
  • This extremely low level is about at the detection level capability of current technology.
  • Contamination can also happen in the distribution system after treatment from the local municipality or private well has already occurred.
  • According to the Environmental Protection Agency, it is recommended to test well water annually to ensure it does not contain harmful contaminants.

Singleton Schreiber Offers Analysis On EPA's Proposed Drinking Water Standards for "Forever Chemicals"

Retrieved on: 
Tuesday, March 14, 2023
Foam, Asthma, Public, Fertility, AFFF, Drinking water, Thyroid disease, Half-life, Death, Health, CDC, Singleton, MCL, PFAS, Centers for Disease Control and Prevention, PFOS, Cancer, Liver, PFOA, MDL, Risk, Injury, EPA, Dupont, District court, Environment, Cosmetics, Environmental remediation

These synthetic chemicals persist in drinking water in more than 2,800 communities throughout the United States and the human body for extended periods of time.

Key Points: 
  • These synthetic chemicals persist in drinking water in more than 2,800 communities throughout the United States and the human body for extended periods of time.
  • The EPA's draft regulations proposed a maximum contaminant level (MCL) in a National Primary Drinking Water Regulation (NPDWR) for six Per- and polyfluoroalkyl substances ("PFAS").
  • The MCL protects public health because it sets a maximum level of contaminant allowed in drinking water from a public water system.
  • By working collaboratively with their local counterparts, these new standards will ensure a cleanup of PFAS and provide for clean and safe drinking water for our communities," said Michael Cassidy, a PFAS geologist and hydrologist for Group Delta (a frequent Singleton Schreiber consultant).

Tampa Thyroid Surgeon Selected as Finalist for Prestigious Tampa Bay Business Women Awards

Retrieved on: 
Thursday, February 2, 2023
Well, Berkeley Preparatory School, Cancer, Woman, Thyroid disease, Berkeley, Patient, Hospital, Empowerment, Geography, Health, Adrenal tumor, Male, Pathology, Thyroid cancer, Internet, Magic, Nursing, Medical device

TAMPA, Fla., Feb. 2, 2023 /PRNewswire/ -- Dr. Rashmi Roy, senior thyroid surgeon at the Clayman Thyroid Center operating at the Hospital for Endocrine Surgery, has been selected as a finalist for Tampa Bay Business & Wealth's Business Women Awards by an outside panel of judges.

Key Points: 
  • TAMPA, Fla., Feb. 2, 2023 /PRNewswire/ -- Dr. Rashmi Roy, senior thyroid surgeon at the Clayman Thyroid Center operating at the Hospital for Endocrine Surgery, has been selected as a finalist for Tampa Bay Business & Wealth's Business Women Awards by an outside panel of judges.
  • The Tampa Bay Business Women Awards is a unique awards program, created by Tampa Bay Business & Wealth Magazine, to recognize distinguished women leaders whose dedication to their industries and communities deserves particular recognition.
  • The Clayman Thyroid Center is a full-service thyroid surgery practice, performing more than 2,000 thyroid operations annually.
  • It specializes in all types of thyroid surgery, including scarless robotic thyroid surgery.

Thrive Health Infusion Centers Launch for Thyroid Eye Disease in Tandem with Thyroid Awareness Month

Retrieved on: 
Wednesday, January 25, 2023
Legal outsourcing, MD, Graves' ophthalmopathy, Hyperthyroidism, Thyroid disease, FDA, Grave, TED, Woman, Patient, Clinical trial, MSO, LOS, Doctor of Philosophy, Autoimmunity, Pharmaceutical industry

LOS ANGELES, Jan. 25, 2023 /PRNewswire-PRWeb/ -- Thrive Health Infusion Centers, founded by Raymond Douglas, MD, PhD, renowned board certified oculoplastic surgeon, with its flagship location in Beverly Hills, California, announces the opening of Long Beach, Newport Beach and San Diego, CA centers creating a leadership presence in the treatment of Thyroid Eye Disease in California. Thrive Health, the first-of-its-kind offering viable, FDA approved non-surgical treatment options as well as clinical trials for new advances in treatment and care for TED and other rare ophthalmic diseases, also opened a New York City flagship.

Key Points: 
  • Thyroid conditions are on the rise with an estimated 20 million Americans having some form of thyroid disease and 1 in 8 women developing a thyroid condition in their lifetime.
  • Thrive Health leverages cutting edge science and expertise in the growing category of medical biologics with leadership in clinical trials.
  • To meet the need of the growing patient population with the autoimmune thyroid condition, the integrated concierge and patient centric medical management treatment centers will announce additional centers in the coming months.
  • Beyond onsite infusion, patient planning and treatment protocols, oversight of benefits approvals, surgical offerings or referrals as needed, Thrive Health is unique in furthering concierge medical collaborations.

Renowned Surgeons Publish Thyroid Nodule Size Chart During Thyroid Disease Awareness Month

Retrieved on: 
Thursday, January 12, 2023
Thyroid, Degenerative disease, Cancer, Neck, Quality of life, Monroe Dunaway Anderson, Surgeon, Hospital, Thyroid cancer, Woman, Thyroid nodule, Growth, Thyroid disease, Patient, Lymph, Biopsy, Hearing, Hashimoto's thyroiditis, Graves' disease, Incidence, Adrenal tumor, Dentistry, Legume, Copper, Medical imaging

TAMPA, Fla., Jan. 12, 2023 /PRNewswire/ -- January is Thyroid Disease Awareness Month, celebrated this year by the thyroid surgeons at the Hospital for Endocrine Surgery by publishing a new thyroid nodule size chart that lay-people can use to determine the significance of any thyroid nodule.

Key Points: 
  • TAMPA, Fla., Jan. 12, 2023 /PRNewswire/ -- January is Thyroid Disease Awareness Month, celebrated this year by the thyroid surgeons at the Hospital for Endocrine Surgery by publishing a new thyroid nodule size chart that lay-people can use to determine the significance of any thyroid nodule.
  • The incidence of having a thyroid nodule increases with age, with most adults over 50 having at least one thyroid nodule.
  • Thyroid nodules are the number one reason for thyroid surgery world-wide, with the need for surgery increasing as the nodule becomes bigger.
  • To produce the thyroid nodule size chart, thyroid surgeons reviewed data from the Center's past 10,000 thyroid surgeries to show the percent chance of needing surgery to remove all or part of the thyroid according to the size of the nodule.

New Down Syndrome Resource Available in Spanish and Japanese

Retrieved on: 
Thursday, December 29, 2022
Dementia, Centro, Degenerative disease, American Medical Association, Diabetes, CUSD, Journal, Sleep apnea, Research, Registry, Osteoporosis, COVID-19, Down syndrome, Ministry of Health (Saudi Arabia), Axis (anatomy), Leukemia, Guideline, Cardiovascular disease, Thyroid disease, Universidad, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Coeliac disease, Obesity, Congress, NIH, Down, El Centro, California, Dietary supplement, Medical device, Pharmaceutical industry, Tourism, Health, Behavior

GLOBAL is working to expand the topics to include sleep apnea, solid tumors, leukemia, vision/eye care, and physical therapy and fitness.

Key Points: 
  • GLOBAL is working to expand the topics to include sleep apnea, solid tumors, leukemia, vision/eye care, and physical therapy and fitness.
  • “GLOBAL is pleased to be able to reach Spanish and Japanese speakers who have Down syndrome and their families in the U.S. in collaboration from the National Institutes of Health/DS-Connect®,” says Michelle Sie Whitten, President & CEO of the Global Down Syndrome Foundation.
  • “It is so important for me and other people with Down syndrome to have this in Spanish,” says Yadiro Carrillo, a 32-year-old self-advocate and entrepreneur who happens to have Down syndrome.
  • To learn more about the GLOBAL Adult Guideline and download your copy today, visit www.globaldownsyndrome.org/medical-care-guidelines-for-adults/
    To learn more about Global Down Syndrome Foundation, visit www.globaldownsyndrome.org

EQS-News: Sernova Announces CEO Succession Plan and Expanded Management Team

Retrieved on: 
Sunday, December 18, 2022
FSE, Clinical trial, CPS, Degenerative disease, Partnership, Thyroid disease, Evotec, T1D, Trial of the century, Haemophilia, Conditional sentence, Diabetes, Survival, Thyroid, TSX, Growth, PSH, Insulin dependent diabetes mellitus 3, Type 1 diabetes, Immune system, Patient, Management, Pharmaceutical industry

LONDON, Ontario -- December 6, 2022 -- Sernova Corp. (Sernova) (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, announced today that, as part of a planned leadership succession process, and after a successful 13-year tenure leading the Company through the development of its pioneering Cell Pouch SystemTM and ensuing growth, Dr. Philip Toleikis, President and Chief Executive Officer will be appointed Sernova’s Chief Technology Officer (CTO). To achieve a seamless transition and continue progress on all Company activities, Dr. Toleikis will remain in the CEO role during the search period and continue to work closely with Executive Chair, Frank Holler.  Mr. Holler will, in particular, take a leadership role and work closely with Dr. Toleikis in advancing Sernova’s business development and corporate finance activities during the search period.

Key Points: 
  • With the Company’s anticipated next phase of growth in US capital markets, it is a natural time to recruit a new CEO.
  • Dr. Toleikis has endorsed this transition plan as it will enable him to focus on accelerating the further development of the Cell Pouch System.”
    Dr. Philip Toleikis joined Sernova in 2009.
  • I am very proud of the Company’s achievements to date, and I look forward to working closely with the new CEO.
  • Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression.

Sernova Corp. Announces CEO Succession Plan and Expanded Management Team

Retrieved on: 
Tuesday, December 6, 2022
FSE, Clinical trial, CPS, Degenerative disease, Partnership, Thyroid disease, Evotec, T1D, Trial of the century, Haemophilia, Conditional sentence, Diabetes, Survival, Thyroid, TSX, Growth, PSH, Insulin dependent diabetes mellitus 3, Type 1 diabetes, Immune system, Patient, Pharmaceutical industry

With the Company’s anticipated next phase of growth in US capital markets, it is a natural time to recruit a new CEO.

Key Points: 
  • With the Company’s anticipated next phase of growth in US capital markets, it is a natural time to recruit a new CEO.
  • Dr. Toleikis has endorsed this transition plan as it will enable him to focus on accelerating the further development of the Cell Pouch System.”
    Dr. Philip Toleikis joined Sernova in 2009.
  • I am very proud of the Company’s achievements to date, and I look forward to working closely with the new CEO.
  • Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression.